Skip to content

Clinical trials

Withdrawn Carcinoma, Hepatocellular trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Not applicable Status: Withdrawn Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20122
20132
20151
20161
20174
20183
20192
20204
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital2
Boston Scientific Corporation1
Fifth Affiliated Hospital, Sun Yat-Sen University1
Fudan University1
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran1
Juan Sanabria, MD1
Karolinska Institutet1
Kwang Hyuck Lee1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular24
Liver Neoplasms3
Bile Duct Neoplasms1
Breast Neoplasms1
Carcinoma, Renal Cell1
Cholangiocarcinoma1
Colonic Neoplasms1
Colorectal Neoplasms1
Gallbladder Neoplasms1
Hepatitis C1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.